255 related articles for article (PubMed ID: 31606057)
21. Epidemiology of acromegaly in Ecuador.
López Gavilanez E; Guerrero Franco K; Solórzano Zambrano N; Navarro Chávez M; López Estrella C; Vaca Burbano L; Marriott Díaz E
Endocrinol Nutr; 2016; 63(7):333-8. PubMed ID: 27158065
[TBL] [Abstract][Full Text] [Related]
22. Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide.
Puglisi S; Ferraù F; Ragonese M; Spagnolo F; Cannavò S
Front Endocrinol (Lausanne); 2020; 11():28. PubMed ID: 32117056
[TBL] [Abstract][Full Text] [Related]
23. [Acromegaly--do we already know everything about treatment of the somatotroph pituitary adenomas?].
Zieliński G; Podgórski JK
Przegl Lek; 2002; 59(7):540-7. PubMed ID: 12516247
[TBL] [Abstract][Full Text] [Related]
24. Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literature.
Endocrine; ; . PubMed ID: 30397873
[TBL] [Abstract][Full Text] [Related]
25.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
